We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CAPTRUST Financial Advisors
201
CAPTRUST Financial Advisors
North Carolina
$73.6M +$11.9M +133,266 +18%
VanEck Associates
202
VanEck Associates
New York
$73.1M -$105M -1,177,605 -58%
FWIA
203
Fort Washington Investment Advisors
Ohio
$72.2M +$1.29M +14,458 +2%
BPC
204
Banque Pictet & Cie
Switzerland
$70.8M +$2.18M +24,407 +3%
Calamos Advisors
205
Calamos Advisors
Illinois
$69.9M +$14.5M +162,388 +25%
BTW
206
Boston Trust Walden
Massachusetts
$68.8M -$533K -5,970 -0.7%
Comerica Bank
207
Comerica Bank
Texas
$68.3M +$298K +3,341 +0.5%
JAM
208
Jupiter Asset Management
United Kingdom
$67.7M +$7.4M +82,929 +12%
Man Group
209
Man Group
United Kingdom
$67.2M +$69.6M +780,120 New
MF
210
Magnetar Financial
Illinois
$66.4M +$23.2M +260,205 +51%
ORIO
211
Old Republic International (ORI)
Illinois
$66.3M -$17.9M -200,000 -21%
Nisa Investment Advisors
212
Nisa Investment Advisors
Missouri
$66.2M -$1.03M -11,504 -1%
GIA
213
Gateway Investment Advisers
Ohio
$65.6M -$605K -6,777 -0.9%
AIA
214
Avalon Investment & Advisory
Texas
$65.4M -$1.57M -17,622 -2%
GLA
215
Great Lakes Advisors
Illinois
$64M -$2.22M -24,901 -3%
PGFC
216
Peapack-Gladstone Financial Corp
New Jersey
$64M +$4.22M +47,247 +7%
USAA
217
United Services Automobile Association
Texas
$63.3M +$384K +4,301 +0.6%
ELI
218
Empire Life Investments
Ontario, Canada
$62.9M +$1.06M +11,868 +2%
SOMRS
219
State of Michigan Retirement System
Michigan
$62.8M +$295K +3,300 +0.5%
Vontobel Holding
220
Vontobel Holding
Switzerland
$62.7M +$8.76M +98,131 +16%
MAM
221
Martingale Asset Management
Massachusetts
$62.6M -$2.24M -25,127 -3%
Los Angeles Capital Management
222
Los Angeles Capital Management
California
$62.3M +$4.58M +51,258 +8%
MIM
223
MetLife Investment Management
New Jersey
$61.7M -$745K -8,343 -1%
FCI
224
Financial Counselors Inc
Kansas
$61.5M +$53K +594 +0.1%
IIM
225
INTECH Investment Management
Florida
$60.1M +$18.6M +208,915 +43%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.